# Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents

> **NCT03619252** · PHASE4 · COMPLETED · sponsor: **Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology** · enrollment: 36 (actual)

## Conditions studied

- Multiple Myeloma
- Pneumococcal Infection
- Febrile Neutropenia
- Pneumococcal Pneumonia

## Interventions

- **BIOLOGICAL:** Vaccination with pneumococcal conjugate vaccine (PCV13)
- **DRUG:** Standard Antibacterial Prophylaxis

## Key facts

- **NCT ID:** NCT03619252
- **Lead sponsor:** Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2021-01-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03619252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03619252, "Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03619252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*